FDA’s Larry Kessler
This article was originally published in The Gray Sheet
Director of the Office of Statistics and Biometrics is slated to take a year-long sabbatical to the Fred Hutchinson Cancer Research Center, starting in September. OSB Deputy Director Susan Gardner will fill in for Kessler. Substituting for Gardner on a rotating basis will be David Daly, director-issues management staff, Gregory Campbell, director of the Division of Biostatistics, and a third person yet to be named...
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.